Deferiprone inhibits iron overload-induced tissue factor bearing endothelial microparticle generation by inhibition oxidative stress induced mitochondrial injury, and apoptosis-Reference-Cited by-同舟云学术

Deferiprone inhibits iron overload-induced tissue factor bearing endothelial microparticle generation by inhibition oxidative stress induced mitochondrial injury, and apoptosis

Published:2018-01 Issue: Volume:338 Page:148-158
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Chan Shing,Lian Qizhou,Chen Mei-Pian,Jiang Dan,Ho Jolie T.K.,Cheung Yiu-Fai,Chan Godfrey Chi-Fung

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference44 articles.

1. Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients;Akrawinthawong;Hematology,2011

2. Hemostatic and thrombotic markers in patients with hemoglobin E/beta-thalassemia disease;Angchaisuksiri;Am. J. Hematol.,2007

3. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease;Boulanger;Hypertension,2006

4. The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation;Braughler;J. Biol. Chem.,1986

5. Calcium, ATP, and ROS: a mitochondrial love-hate triangle;Brookes;Am. J. Phys. Cell Phys.,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Up-regulated FOXO3/IL-10 Axis Inhibits Mitochondria-Associated Ferroptosis in Sepsis-Induced Diaphragm Dysfunction;2024-07-12

2. Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review;Drug Design, Development and Therapy;2024-04

3. Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature;American Journal of Cardiovascular Drugs;2023-12-29

4. Iron accumulation and lipid peroxidation: implication of ferroptosis in diabetic cardiomyopathy;Diabetology & Metabolic Syndrome;2023-07-19

5. The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases;Pharmaceuticals;2023-07-18